Equities Research Analysts’ upgrades for Tuesday, October 10th:

Abbott Laboratories (NYSE:ABT) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $61.00 target price on the stock. According to Zacks, “Over the past three months, Abbott has been trading above the broader industry. Abbott’s second-quarter 2017 performance was promising. The raised guidance is indicative of brighter prospects. In fact, the guidance raise was backed by the company’s expectations to gain more synergies from the St. Jude merger. Overall, we look forward to Abbott’s plans to expand in core therapeutic areas. Recently, the company's  FreeStyle Libre Flash received the FDA approval. Also, the company has received FDA approval for magnetic resonance-conditional labeling for its Ellipse implantable cardioverter defibrillator recently. On the flip side, Abbott’s sluggish pediatric business in China continues to dent growth. Management is also concerned about the economic problems in Venezuela that are expected to remain unresolved for some time. Meanwhile, we await the closing of the Alere buyout, slated for close on Oct 3.”

Analog Devices (NASDAQ:ADI) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $98.00 target price on the stock. According to Zacks, “Analog Devices is a leading supplier of analog and DSP integrated circuits. The company delivered better-than-expected fiscal third-quarter 2017 results beating the Zacks Consensus Estimate on both counts. Results were driven by strength across all the markets and positive contributions from Linear Technology acquisition. Analog Devices' leading market position, focus on communications, automotive and industrial markets, margin expansion initiatives and strong balance sheet are positives. However, we remain concerned about competitive pressures across several markets. Year to date, the stock has underperformed the industry it belongs to.”

AmTrust Financial Services (NASDAQ:AFSI) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “AmTrust Financial’s leadership position in commercial small business, expansion of other segments and an impressive inorganic growth story poise it well for growth. The company also aims to build an investment portfolio that returns in line with the sector. The slow but improving rate environment also raises optimism. Plus, a strong balance sheet facilitates growth initiatives and effective capital deployment. However, being a property and casualty insurer, the company remains exposed to cat environment, including volatility in underwriting results. Also, a high level of debt increases interest burden and escalates expenses, hurting margin. Shares of AmTrust Financial have underperformed the industry year to date. Moreover, the company did not witness any estimate revisions for its 2017 and 2018 estimates over the last 60 days.”

Avnet (NYSE:AVT) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $45.00 price target on the stock. According to Zacks, “Avnet is one of the world’s largest distributors of electronic components and computer products. The divestment of the Technology Solution division has allowed Avnet to focus on high-growth areas such as marketing electronic components and related products in the supply chain. The company intends to use its resources to make investments in embedded solutions, IoT and critical digital platforms as well as expand its footprint in newer markets. Furthermore, acquisitions such as Premier Farnell and Dragon Innovation are likely to bolster Avnet’s portfolio and expand global operations. Nonetheless, a significant portion of Avnet’s revenues comes from the sale of semiconductors, which is a cyclical industry, characterized by changes in technology and manufacturing capacity and subject to significant market upturns and downturns. Notably, the stock has underperformed the industry over the last one year.”

Baxter International (NYSE:BAX) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $69.00 target price on the stock. According to Zacks, “Over the past year, Baxter has outperformed the broader industry in terms of price performance. The company rides on the recent launch of DeviceVue, a comprehensive asset tracking solution available exclusively to hospitals. However, lower cyclophosphamide sales in the coming quarters might mar the Baxter’s bottom line. Of the major positives, a favorable product mix, stringent cost control and expanding operating margin are notable. Baxter reported impressive results in the second quarter, driven by favorable tidings on the regulatory front, strategic partnerships and product launches. The company recently completed the acquisition of Claris Injectables. Solid U.S. sales of IV therapies, IV access sets, select anesthesia and critical care products are key catalysts at the moment. On the flipside, a strong U.S. dollar, intensifying competition and lackluster sales growth are key concerns at the moment.”

Barclays PLC (NYSE:BCS) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $11.00 price target on the stock. According to Zacks, “Barclays' shares on NYSE have significantly underperformed the industry over the last six months. The company has surpassed the Zacks Consensus Estimate for earnings in only one of the trailing four quarters. Also, the company has been facing pressure on revenues owing to weak global economic recovery and uncertainty related to Brexit. However, the bank's restructuring and simplifying efforts ended successfully leading to the closure of the Non-Core division and continued decline in expenses. A strong balance sheet position is another positive for the company.”

Bank Of New York Mellon Corporation (The) (NYSE:BK) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $61.00 target price on the stock. According to Zacks, “BNY Mellon's shares have outperformed the industry in the last six months. The performance was supported by the company’s decent earnings surprise history. It surpassed the Zacks Consensus Estimate for earnings in two of the trailing four quarters. Easing margin pressure (driven by gradual rise in interest rates), potential lesser regulations, cost-saving initiatives and rising loan demand are expected to aid profitability. Also, the company's steady capital deployment activities reflect strong capital position. However, concentration risk arising from significant dependence on fee-based income remains a matter of concern in the near term.”

Cullen/Frost Bankers (NYSE:CFR) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Shares of Cullen/Frost have outperformed the industry year to date. This performance was supported by the company’s impressive earnings surprise history. It has surpassed the Zacks Consensus Estimate for earnings in three of the trailing four quarters. With a rising interest rate environment and improving non-interest bearing deposits, the company's net interest income and net interest margin is expected to grow. However, rising costs stemming mainly from expanding franchise are likely to deter bottom-line growth to some extent. Also, the company’s risky loan portfolio keeps us apprehensive.”

Cooper Companies, Inc. (The) (NYSE:COO) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $265.00 target price on the stock. According to Zacks, “The Cooper Companies had an impressive run on the bourse over the last six months. The company ended third-quarter fiscal 2017 on a solid note, beating the Zacks Consensus Estimate on both lines. The Cooper Companies has always seen impressive results at its CooperVision business segment. Notably, the segment banks on the platforms of MyDay, Clariti and Biofinity silicone hydrogel lenses. The CooperSurgical segment also delivered strong sales in the quarter. The company provided strong guidance for fiscal 2017. However, the dampening outlook for the CooperSurgical segment indicates looming concerns. Furthermore, intensifying competition in the contact lens space will continue to increase pricing pressure. Cooper Companies has completed the acquisition of Procornea in the recent past. This added a leading ortho-k technology to Cooper Company’s lens portfolio and marked its foray in the emerging myopia controlled markets.”

Cognizant Technology Solutions Corporation (NASDAQ:CTSH) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $82.00 price target on the stock. According to Zacks, “Cognizant's strong growth can be attributed to its significant exposure to the fast-growing verticals like Financial Services and Healthcare. The company narrowed its top-line guidance for 2017, which reflects improved visibility. Moreover, the company raised its earnings guidance. We believe that the results and the guidance indicate the company’s ability in harnessing the ongoing digital transition. The company is significantly benefiting from accretive acquisitions. Cognizant has gained deep industry expertise and knowledge of the domains through partnerships with top firms like Microsoft and SAP.  Moreover, this strategy has enabled the company to deliver more value to clients and capitalize on new opportunities. However, stiff competition in the IT services market is a concern.”

CyberArk Software (NASDAQ:CYBR) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “CyberArk is an Israeli company that specializes in protecting accounts from cyber-attacks. Given a healthy security market, we are optimistic about the company’s product lineup, deal wins and investment plans, which will boost results in the long run. Furthermore, CyberArk’s expansion strategy through acquisitions is encouraging. Investments in product suite and go-to market are the other positives for the company. According to research firm, Markets and Markets, the cyber security market is expected to touch $170.21 billion by 2020 from $106.32 billion in 2015, expanding at an annual rate of 9.8%. We believe that CyberArk Software is in a favorable position to tap the opportunities. However, the stock has underperformed the industry over the last one year. Decelerating revenue growth trend makes us slightly cautious about its near-term performance. Stiff competition from peers and an uncertain macroeconomic environment add to woes.”

DXC Technology Company. (NYSE:DXC) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $99.00 target price on the stock. According to Zacks, “DXC Technology is a result of merger between CSC and Enterprise Services Division of HPE. We believe that the merger has opened new avenues of growth for the combined company. Recently, DXC expanded its ties with VMware. We believe that the partnership will enable DXC to offer an efficient and improved hybrid IT environment to drive performance. Going ahead, following the footsteps of Computer Sciences, DXC Technology may be seen making strategic acquisitions to strengthen its portfolio, which should drive growth over the long run. Notably, the company has outperformed the industry over the past one year. Nonetheless, rising interest expenses due to increased debt burden may dampen its profitability. Additionally, a challenging macroeconomic situation and uncertain IT spending environment remain other headwinds.”

Essex Property Trust (NYSE:ESS) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $289.00 target price on the stock. According to Zacks, “Shares of Essex Property outperformed the industry it belongs to year to date. Moreover, the stock has seen the Zacks Consensus Estimate for current-year funds from operations (FFO) per share being revised upward in two months’ time. Notably, the company delivered a better-than-expected performance for second-quarter 2017. Results reflect solid growth in revenues. With a strong property base and solid balance sheet, Essex is likely to leverage on favorable demographic trends in its markets. The company’s substantial exposure to the West Coast market, which is home to several innovation and technology companies, offers ample scope to boost its top line over the long term. Moreover, it has a 23-year history of increasing cash dividend. However, in the upcoming period, large concession amid elevated supply is likely to result in periodic disruption in certain submarkets. Also, rate hike adds to its woes.”

E*TRADE Financial Corporation (NASDAQ:ETFC) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $50.00 target price on the stock. According to Zacks, “Shares of E*TRADE have outperformed the industry so far this year. The performance was supported by the company’s impressive earnings surprise history. It has surpassed the Zacks Consensus Estimate for earnings in all the trailing four quarters. E*TRADE’s several restructuring measures and balance-sheet growth plans keep us encouraged. We anticipate the company’s focus on core operations and strategic initiatives to lead to an improved performance of the top-line. Further, the company’s improving credit quality and strong capital position will aid profitability. However, E*TRADE’s escalating expenses and intense competition remain near-term concerns.”

FactSet Research Systems (NYSE:FDS) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $200.00 target price on the stock. According to Zacks, “The Global business information service provider, FactSet recently reported better-than-expected results for the fourth quarter. Moreover, we are encouraged by favorable year-over-year comparisons on both counts as well as an impressive guidance for the first quarter of fiscal 2018. FactSet’s sustained focus on product innovation across segments with an emphasis on financial services to expand the customer base has helped keep afloat amid the current macroeconomic challenges. Moreover, its strategy of growing through acquisitions is praiseworthy. However, increasing competition from Bloomberg, Dow Jones & Company, MSCI and Thomson Reuters, which are also coming up with substitute products at competitive prices, is a material headwind for the company. Notably, FactSet has underperformed the industry to which it belongs to in the year-to-date period.”

Federated Investors (NYSE:FII) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $34.00 price target on the stock. According to Zacks, “Shares of Federated have underperformed the industry over the last six months. Yet, the company boasts an impressive earnings surprise history. It surpassed the Zacks Consensus Estimate for earnings in all the trailing four quarters. Rise in interest rates and lower fee waivers are expected to aid top-line performance, moving ahead. Also, Federated’s inorganic growth strategies encourage us. Further, the company’s active involvement in capital deployment activities continues to inspire investors’ confidence. However, mounting expenses are a major concern. Also, strict regulations for investment management companies remain a headwind.”

HP (NYSE:HPQ) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $23.00 target price on the stock. According to Zacks, “Shares of technology giant, HP has outperformed the industry on a year-to-basis. The company’s efforts to turn around the business have been commendable. HP is working on product innovation, differentiation and enhancing the capabilities of its printing business to stabilize the top line. Furthermore, looking at the recently released data on PC shipment by IDC depicts that HP’s restructuring initiatives which includes divestment of non-core assets and cutting jobs to lower costs along with focus on product innovations, pricing, marketing and sales activities, are paying off. Nonetheless, pricing pressure due to intense competition remains a major concern. Moreover, a tepid IT spending environment adds to its woes.”

Integra LifeSciences Holdings Corporation (NASDAQ:IART) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $55.00 target price on the stock. According to Zacks, “Over the last six months, Integra Lifesciences has been trading above the broader industry. Moreover, the strong year over year increase in revenue on the back of solid performance of its Orthopedics and Tissue Technologies’ segment buoys optimism. We believe the company’s recent product diversification bolstered investors’ confidence, thereby boosting the stock price further. On the flip side, the company exited the second quarter of 2017 on somewhat disappointing note with earnings in line with the estimates and revenues missing the mark. We are concerned about the currency headwind that is expected to affect Integra’s financial performance in the rest of 2017. Also, contraction in adjusted operating margin and adjusted gross margin adds to the woes.”

Manulife Financial Corp (NYSE:MFC) (TSE:MFC) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $23.00 price target on the stock. According to Zacks, “Shares of Manulife outperformed the industry in a year’s time. Moreover, the company witnessed its 2017 and 2018 estimates moving north over the last 60 days. Manulife continues to witness new business volumes, particularly in Asia, and positive net flows in its wealth and asset management businesses. Deep reach in the Asian market and a growing asset management business would drive long-term earnings growth. The company remains on track to achieve more than $100 million in expense synergies. However, declining group benefit sales in Canada segment will weigh on results, volatile global equity markets coupled with low bond yields has largely affected the company’s capital position.”

Palo Alto Networks (NYSE:PANW) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $164.00 price target on the stock. According to Zacks, “Palo Alto allows firms, service providers and government bodies to impose tighter security measures through its network security platform. Revenue growth seems to be steady, aided by strength across all its geographical regions and business segments. Also, customer wins coupled with expansion of the existing customer base are the other positives. We believe that the company’s product refreshes and acquisitions synergies will boost revenues, going forward. Also, the strategic partnerships with the likes of VMware, Splunk and Citrix, will continue to bring in customers for Palo Alto thereby boosting the top line. Notably, the stock has outperformed the industry over the last six months. Nonethess, a volatile spending environment and competition from Cisco Systems and Check Point Software Technologies remain concerns.”

Pepsico (NYSE:PEP) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $123.00 target price on the stock. According to Zacks, “PepsiCo reported mixed third-quarter 2017 results, with earnings beating the Zacks Consensus Estimate and revenues missing the same. Nonetheless, this is the sixth consecutive quarter of positive earnings surprise. On a year-over-year basis, core earnings and revenues grew 6% and 1.3%, respectively. PepsiCo has been doing well on the back of significant innovation, continued momentum in Frito-Lay business, revenue management strategies, improved productivity and cost-saving initiatives, along with better market execution. Revenues increased 1.7% on an organic basis, primarily driven by higher demand for beverages/food/snacks in the Asia, Middle East and North Africa, Europe Sub-Saharan Africa and Latin America segments. Total volumes however declined 1% during the quarter against flat growth in the previous quarter. Core gross margins also contracted 15 basis points.”

Dave & Buster’s Entertainment (NASDAQ:PLAY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $55.00 price target on the stock. According to Zacks, “Dave & Buster's shares have outpaced the industry over the past year. The company’s unique business model with increased dependence on gaming sets it apart and we expect the company’s entertainment business to carry the growth story forward. Consistent efforts to build sales and improve margins through various initiatives have also been key growth drivers. In this regard, continual opening of stores, menu innovation, launch of games, and the Fun American New Gourmet and beverage options are expected to continue boosting its top and bottom lines. In fact, the second quarter of fiscal 2017 marked the 12th successive earnings beat for the company. However, rising labor costs and a non-franchised business model might hurt profits, while a soft consumer spending environment in the U.S. restaurant space could impact comps.”

PNC Financial Services Group, Inc. (The) (NYSE:PNC) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $152.00 price target on the stock. According to Zacks, “Shares of PNC Financial have outperformed the industry, so far, this year. The performance was supported by the company’s impressive earnings surprise history. It hasn’t missed the Zacks Consensus Estimate for earnings in any of the trailing four quarters. The company benefits from robust organic growth and strong balance sheet position. Further, we remain encouraged by the company’s efforts to generate positive operating leverage through its cost-saving initiatives. Its deal to acquire the commercial and vendor finance business of ECN Capital is anticipated to be marginally accretive to earnings in 2017. However, the company’s capital deployment activities do not seem sustainable. Also, a stretched valuation reflects limited upside potential.”

Prudential Financial (NYSE:PRU) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $122.00 target price on the stock. According to Zacks, “Shares of the company outperformed the industry in a year’s time. Moreover, the company saw its 2017 and 2018 estimates move north in the last 60 days. Prudential Financial remains well poised for growth on the back of its high performing asset management business, international operations and deeper reach in the pension risk transfer market. It strives to build leadership position in the pension risk transfer market. Expanded international presence provides it with better organic growth opportunities than peers. Also, a strong balance sheet and efficient capital management are tailwinds. It now expects ROE between 12% and 13% in the near to intermediate-term. However, exposure to low interest rates, unfavorable currency impact and regulatory control remain headwinds.”

Qiagen N.V. (NASDAQ:QGEN) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $39.00 price target on the stock. According to Zacks, “QIAGEN’s commitment to return more to its shareholders through increased share repurchases reflects solid cash position. We are also upbeat about QIAGEN’s partnership and co-marketing agreement with CENTOGENE AG to boost its bioinformatics portfolio. Moreover, the company’s strategic focus to drive growth through Sample to Insight offerings buoys optimism. QIAGEN is forming collaborations in the personalized homecare space also. Moreover, QIAsymphony continued to grow towards the target of 2,000 cumulative placements by 2017 end. On the flip side, over the last three months, QIAGEN has been trading below the broader industry. Moreover, adverse currency translation continues to be a drag on overall sales. Furthermore, declining HPV sales in the United States continues to be a drag. Competitive landscape and strong reliance on collaborations also continue to be concerns.”

Radian Group (NYSE:RDN) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $21.00 price target on the stock. According to Zacks, “Shares of Radian Group have outperformed the insurance industry in a year. Radian Group is poised for long-term growth on expansive mortgage and real estate service offerings, declining delinquency, lower levels of paid claims and improving risk-based capital ratio. The company has received rating upgrades owing to a string of capital takes undertaken by the company and is thus on track to return to an investment grade rating. Its initiatives to solidify the financial position and improved debt maturity profile bode well. However, stricter regulations, rising mortgage rates and a competitive market pose risks for Radian Group. The company expects expenses to be between $62 million and $66 million each quarter. Radian is set to announce third quarter result on Oct 26. Our proven model conclusively show that the company is likely to beat on earnings this time because it has a right combination of Zacks Rank #2 and an Earnings ESP of +1.16%.”

Regency Centers Corporation (NYSE:REG) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $70.00 price target on the stock. According to Zacks, “Shares of Regency have underperformed its industry, year to date. However, the stock has seen the Zacks Consensus Estimates for 2017 and 2018 funds from operations (FFO) per share being revised upward in a month’s time. It did not report any significant damage from the recent hurricanes. The company’s focus on building a premium portfolio of grocery-anchored shopping centers, which are usually necessity-driven, along with the presence of leading grocers in its tenant roaster, augurs well. Also, Regency’s merger with Equity One elevated the company’s position in the retail real estate market and offered it a host of opportunities to drive growth. Yet, the recent efforts of online retailers to go deeper into the grocery business have emerged as a concern for this real estate investment trust (REIT).”

Red Robin Gourmet Burgers (NASDAQ:RRGB) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $73.00 target price on the stock. According to Zacks, “We note that 2016 was a tough year for Red Robin given the impact of acquiring lower-margin franchise restaurants and higher labor cost that hurt margins. Soft industry trends added to the woes. Nonetheless, efficient menu innovation, focus on increasing service speed, effective marketing strategy and remodeling programs to reinvigorate brands have brought the growth story back on track. As a result, shares of the company outperformed the industry year to date. However, a slowdown in company’s 2017 unit growth plan given the persistent challenges in the U.S. restaurants space along with cost-related issues raise concerns. Even so, initiatives undertaken to improve sales and regain market share as the year progresses, bodes well.”

Sun Life Financial (NYSE:SLF) (TSE:SLF) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $45.00 target price on the stock. According to Zacks, “Sun Life’s aggressive re-designing of products, improved pricing, and focus on segments with higher growth and return complemented by market factor of reduced interest rate and market risk bode well. A strong balance sheet and effective capital deployment in growth initiatives will fuel earning, ROE and enhance shareholders’ value. The company continues to forge ahead with its digital and wealth initiatives in Canada, strong sales momentum in Asia, the scaling and integration of its U.S. operations, and strong long-term investment performance in asset management businesses. It targets medium-term EPS growth between 8% and 10%. The company also witnessed estimates moving north over the last 60 days. However, exposure to macro headwinds, regulatory uncertainties and low rates are headwinds. Also, shares of Sun Life Financial underperformed industry quarter to date.”

Sysco Corporation (NYSE:SYY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $60.00 target price on the stock. According to Zacks, “Sysco’s shares have outpaced the industry in the past year, primarily backed by its strategic initiatives. Armed with a strong business portfolio, the company has been gaining from its recent acquisitions. Evidently, the acquisition of London-based Brakes Group led to an increase of 5.7% of sales on a year-over-year basis in the fourth-quarter fiscal 2017. Notably, the company’s sales have improved consistently driven by acquisitions and volume growth. Sysco’s efforts to boost sales and margins are paying up, as the company has delivered positive gross margins in the last nine quarters, after declining consistently since past several quarters. However, macroeconomic headwinds including stiff competition and aggressive promotional environment remain major concerns.”

TCF Financial Corporation (NYSE:TCF) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Shares of TCF Financial have underperformed the industry year to date. Also, the company’s earnings surprise history is not impressive. It missed the Zacks Consensus Estimate for earnings in two of the trailing four quarters. The company remains affected by the consistently declining banking fees for the last few years. Further, mounting expenses primarily driven by growth in staff level remains a near-term headwind. However, increasing loans, strong deposit mix and easing margin pressure will likely to aid profitability. The company has been benefiting from improving credit quality in consumer real estate portfolio and has witnessed enhanced profitability ratios as well, which keeps us encouraged.”

Toll Brothers (NYSE:TOL) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $48.00 price target on the stock. According to Zacks, “Toll Brothers’ shares have outperformed the industry in the last one year. Strong housing demand and lack of competition in the luxury new home market is expected to drive Toll Brothers’ revenues. Also, the 2017 outlook for the U.S. homebuilding industry is quite compelling given the affordable interest rates and tight inventory indicating pent-up demand. However, we are concerned about the escalating building material and labor costs that are proving to be a drag on margins.”

United Natural Foods (NASDAQ:UNFI) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $45.00 target price on the stock. According to Zacks, “Shares of United Natural have outpaced the industry in the past three months, primarily backed by its growth initiatives. In the recently reported fourth-quarter fiscal 2017, the company’s earnings benefited from the sale of its stake holdings in Kicking Horse coffee. This indicates that the company has been making solid progress with its rationalizing efforts. Additionally, acquisition-related benefits have been aiding the United Natural’s top-line growth for a while now. Evidently, in the reported quarter, its top line depicted a year-on-year gain of 5.7% owing to Gourmet Guru and Haddon House acquisitions. Also, the company has been gaining from increased consumer preference for natural and organic brands, in spite of the ongoing industry challenges. We also note that United Natural has a murky sales surprise history as the company’s top line has lagged estimates for 11 straight quarters now.”

Venator Materials PLC (NASDAQ:VNTR) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. They currently have $26.00 price target on the stock. According to Zacks, “Venator Materials PLC is a manufacturer and marketer of chemical products. The company’s product comprises a broad range of pigments and additives that bring color and vibrancy to building, protect and extend product life and reduce energy consumption. Its operating segment consists of Titanium Dioxide, which consists of our TiO2 business, and Performance Additives, which consists of our functional additives, color pigments, timber treatment and water treatment businesses. Venator Materials PLC is headquartered in The Woodlands, Texas. “

Receive News & Ratings for Abbott Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abbott Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.